Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 2, 2010, Pages 187-191

  Stoops, William W ^a   Lile, Joshua A ^a   Rush, Craig R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alternative reinforcer; Cocaine; Humans

Indexed keywords

COCAINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG CHOICE; DRUG DEPENDENCE TREATMENT; FEMALE; FOOD; HUMAN; INTRANASAL DRUG ABUSE; MALE; MONEY; PRIORITY JOURNAL; REINFORCEMENT; RISK REDUCTION;

ADMINISTRATION, INTRANASAL; COCAINE; HUMANS; MOTIVATION; PLACEBOS;

EID: 76949099270     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.01.003     Document Type: Article

References (32)

1. Bickel W.K., and Marsch L.A. Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 96 (2001) 73-86
2. Collins S.L., Levin F.R., Foltin R.W., Kleber H.D., and Evans S.M. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend 82 (2006) 158-167
3. Donny E.C., Bigelow G.E., and Walsh S.L. Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval and magnitude of alternative reinforcement. Drug Alcohol Depend 69 (2003) 289-301
4. Donny E.C., Bigelow G.E., and Walsh S.L. Assessing the initiation of cocaine self-administration in humans during abstinence: effects of dose, alternative reinforcement, and priming. Psychopharmacology 172 (2004) 316-323
5. Grabowski J., Higgins S.T., and Kirby K.C. Behavioral treatments of cocaine dependence. NIDA monograph 135 (1993) 133-149
6. Haney M., Hart C., Collins E.D., and Foltin R.W. Smoked cocaine discrimination in humans: effects of gabapentin. Drug Alcohol Depend 80 (2005) 53-61
7. Hart C.L., Haney M., Foltin R.W., and Fischman M.W. Alternative reinforcers differentially modify cocaine self-administrative humans. Behav Pharmacol 11 (2000) 87-91
8. Hatsukami D.K., Thompson T.N., Pentel P.R., Flygare B.K., and Carroll M.E. Self-administration of smoked cocaine. Exp and Clin Psychopharmacol 2 (1994) 115-125
9. Higgins S.T. The influence of alternative reinforcers on cocaine use and abuse: a brief review. Pharmacol Biochem Behav 57 (1997) 419-427
10. Higgins S.T., Bickel W.K., Hughes J.R., Lynn M., Capeless M.A., and Fenwick J.W. Effects of intranasal cocaine on human learning, performance and physiology. Psychopharmacology 10 (1990) 451-458
11. Higgins S.T., Delaney D.D., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., and Fenwick J.W. A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry 148 (1991) 1218-1224
12. Higgins S.T., Bickel W.K., and Hughes J.R. Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 55 (1994) 179-187
13. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Donham R., and Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 51 (1994) 568-576
14. Higgins S.T., Roll J.M., and Bickel W.K. Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology 123 (1996) 1-8
15. Higgins S.T., Badger G.J., and Budney A.J. Initial abstinence and success in achieving longer term cocaine abstinence. Exp Clin Psychopharmacol 8 (2000) 377-386
16. Higgins S.T., Alessi S.M., and Dantona R.L. Voucher-based incentives: a substance abuse treatment innovation. Addict Behav 27 (2002) 887-910
17. Javaid J.I., Fischman M.W., Schuster C.R., Dekirmenjian H., and Davis J.M. Cocaine plasma concentration: relation to physiological and subject-rated effects in humans. Science 202 (1978) 227-228
18. Nader M.A., and Woolverton W.L. Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure. Psychopharmacology 105 (1991) 169-174
19. Petry N.M., Alessi S.M., Marx J., Austin M., and Tardif M. Vouchers versus prizes: contingency management treatment of substance abusers in community settings. J Consult Clin Psychol 73 (2005) 1005-1014
20. Petry N.M., Alessi S.M., Hanson T., and Sierra S. Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. J Consult Clin Psychol 75 (2007) 983-991
21. Poling J., Oliveto A., Petry N., Sofuoglu M., Gonsai K., Gonzalez G., Martell B., and Kosten T.R. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry 63 (2006) 219-228
22. Reilly M.P., Roll J.M., and Downey K.K. Impulsivity and voucher versus money preference in polydrug-dependent participants enrolled in a contingency-management-based substance abuse treatment program. J Subst Abuse Treat 19 (2000) 253-257
23. Rush C.R., Baker R.W., and Wright K. Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis. Drug Alcohol Depend 55 (1999) 1-12
24. Rush C.R., Stoops W.W., Wagner F.P., Hays L.R., and Glaser P.E.A. Risperidone attenuates the behavioral effects of d-amphetamine in humans. J Pharmacol Exp Ther 306 (2003) 195-204
25. Schmitz J.M., Mooney M.E., Moeller F.G., Stotts A.L., Green C., and Grabowski J. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug Alcohol Depend 94 (2008) 142-150
26. Selzer M.L. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127 (1971) 1653-1658
27. Skinner H.A. The drug abuse screening test. Addict Behav 7 (1982) 363-371
28. Stitzer M.L., and Walsh S.L. Psychostimulant abuse: the case for combined behavioral and pharmacological treatments. Pharmacol Biochem Behav 57 (1997) 457-470
29. Stoops W.W., Lile J.A., Lofwall M.R., and Rush C.R. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. Am J Drug Alcohol Abuse 33 (2007) 769-776
30. Vandrey R., Bigelow G.E., and Stitzer M.L. Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives. Exp Clin Psychopharmacol 15 (2007) 338-343
31. Walsh S.L., Geter-Douglas B., Strain E.C., and Bigelow G.E. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther 299 (2001) 147-158
32. Zacny JP, Divane WT, De Wit H. Assessment of magnitude and availability of a non-drug reinforcer on preference for a drug reinforcer. Hum Psychopharmacol 1992; 7:281-286.